Similar articles for PMID: 14602859

Year	Number of Results
1935	1
1998	1
1999	4
2000	2
2001	3
2002	4
2003	9
2004	4
2005	7
2006	5
2007	3
2008	4
2009	2
2010	6
2011	2
2012	1
2013	2
2014	2
2015	2
2016	2
2017	1
2018	1
2019	2
2020	2
2024	0

1

Delayed (18)F-FDG PET for detection of paraaortic lymph node metastases in cervical cancer patients.

Ma SY, See LC, Lai CH, Chou HH, Tsai CS, Ng KK, Hsueh S, Lin WJ, Chen JT, Yen TC. Ma SY, et al. J Nucl Med. 2003 Nov;44(11):1775-83. J Nucl Med. 2003. PMID: 14602859 Free article.

2

Evaluation of FDG PET in patients with cervical cancer.

Sugawara Y, Eisbruch A, Kosuda S, Recker BE, Kison PV, Wahl RL. Sugawara Y, et al. J Nucl Med. 1999 Jul;40(7):1125-31. J Nucl Med. 1999. PMID: 10405131 Free article.

3

Preliminary report of using FDG-PET to detect extrapelvic lesions in cervical cancer patients with enlarged pelvic lymph nodes on MRI/CT.

Tsai CS, Chang TC, Lai CH, Tsai CC, Ng KK, Hsueh S, Yen TC, Hong JH. Tsai CS, et al. Int J Radiat Oncol Biol Phys. 2004 Apr 1;58(5):1506-12. doi: 10.1016/j.ijrobp.2003.09.013. Int J Radiat Oncol Biol Phys. 2004. PMID: 15050330

4

Evaluation of dual-time-point 18F-FDG PET for staging in patients with lung cancer.

Uesaka D, Demura Y, Ishizaki T, Ameshima S, Miyamori I, Sasaki M, Fujibayashi Y, Okazawa H. Uesaka D, et al. J Nucl Med. 2008 Oct;49(10):1606-12. doi: 10.2967/jnumed.108.051250. Epub 2008 Sep 15. J Nucl Med. 2008. PMID: 18794269 Free article.

5

Prospective evaluation of 18-fluoro-2-deoxy-D-glucose positron emission tomography for the discrimination of paraaortic nodal spread in patients with locally advanced cervical carcinoma.

Perez-Medina T, Pereira A, Mucientes J, García-Espantaleón M, Jiménez JS, Calles L, Rodríguez B, Iglesias E. Perez-Medina T, et al. Int J Gynecol Cancer. 2013 Jan;23(1):170-5. doi: 10.1097/IGC.0b013e3182784289. Int J Gynecol Cancer. 2013. PMID: 23196756 Clinical Trial.

6

Value of FDG PET in papillary thyroid carcinoma with negative 131I whole-body scan.

Chung JK, So Y, Lee JS, Choi CW, Lim SM, Lee DS, Hong SW, Youn YK, Lee MC, Cho BY. Chung JK, et al. J Nucl Med. 1999 Jun;40(6):986-92. J Nucl Med. 1999. PMID: 10452315 Free article.

7

Detection of early recurrence with 18F-FDG PET in patients with cervical cancer.

Ryu SY, Kim MH, Choi SC, Choi CW, Lee KH. Ryu SY, et al. J Nucl Med. 2003 Mar;44(3):347-52. J Nucl Med. 2003. PMID: 12620999 Free article.

8

Lymph node assessment with (18)F-FDG-PET and MRI in uterine cervical cancer.

Monteil J, Maubon A, Leobon S, Roux S, Marin B, Renaudie J, Genet D, Fermeaux V, Aubard Y, Tubiana-Mathieu N. Monteil J, et al. Anticancer Res. 2011 Nov;31(11):3865-71. Anticancer Res. 2011. PMID: 22110211

9

FDG PET-CT in cervical cancer: relationship between primary tumor FDG uptake and metastatic potential.

Yilmaz M, Adli M, Celen Z, Zincirkeser S, Dirier A. Yilmaz M, et al. Nucl Med Commun. 2010 Jun;31(6):526-31. doi: 10.1097/MNM.0b013e32833800e7. Nucl Med Commun. 2010. PMID: 20215979

10

Positron emission tomography in evaluating the feasibility of curative intent in cervical cancer patients with limited distant lymph node metastases.

Chao A, Ho KC, Wang CC, Cheng HH, Lin G, Yen TC, Lai CH. Chao A, et al. Gynecol Oncol. 2008 Aug;110(2):172-8. doi: 10.1016/j.ygyno.2008.03.018. Epub 2008 May 22. Gynecol Oncol. 2008. PMID: 18499238

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

65 results

Results by year